Navigation Links
Don't Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on Innovation in IT, Cell-Based Therapy and Supply Chains
Date:9/9/2009

NEW YORK, Sept. 9 /PRNewswire/ -- Future Pharmaceuticals features an exclusive interview with Dave Champagne, Vice President and General Manager of Informatics at Thermo Fisher Scientific, and Thor-Gunnar Steinsli, LIMS Manager and Chief Engineer at HUNT Research Center and Biobank, about data integration: the benefits of data, instrument and enterprise integration strategies and challenges at life sciences companies.

"One of the biggest challenges facing life sciences companies has to do with managing the ever-growing volume of data and connecting all of the disparate sources of data throughout an organization," Champagne said.

"HUNT Biobank is a vivid example of the benefits of this type of integrated solution who helped us secure Microsoft's prestigious Pharmaceutical and Life Sciences Innovation Award in Discovery and Product Innovation (for more information visit http://www.thermo.com/informatics)," Champagne added.

The Director of Global Quality Labs at Eli Lilly, Jackie Larew, is featured in this issue leading an expert panel around issues facing the supply chain. One of the questions she poses to the panel is around the recent concerns we've seen with pet food and milk products tainted with melamine and contaminated heparin entering the U.S. supply chain. "What implications does this have for the way pharmaceutical companies ensure quality from their suppliers with an increasingly global supply chain of raw materials?" Larew asked the panelists.

This edition of FP also delves into the changing world of cell-based therapy. Mark Thiede, Research Fellow with Pfizer for the Genetically Modified Models Center of Emphasis, guest moderates a panel discussion on the future of the cellular therapy industry. Read the piece, Diagnosis: Cell-based Therapy, for their insights.

About Future Pharmaceuticals

Future Pharmaceuticals magazine draws connections between industry leaders and pharmaceutical companies. Future Pharmaceuticals recommends next generation and groundbreaking strategies to ensure success across the enterprise.

About Analysts In Media

AIM Inc., headquartered in New York City, is a leading global provider of high-quality, comprehensive information for the professional and enthusiast markets. Through progressive research, surveys and client case studies from visionaries and leaders in the industry, AIM provides access to its validated knowledge via targeted multi-media channels, publications, events and online services.

For more information, visit www.FuturePharmaUS.com


'/>"/>
SOURCE Future Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology
2. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
3. Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
4. Beike Biotech Adds International Executives to Strengthen Current Technologies and Develop Future Pipeline
5. California Life Science, Business, and Economic Development Experts Discuss Californias Bioscience Future
6. New nanolaser key to future optical computers and technologies
7. Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies
8. Industry Leaders Will Gather to Discuss the Future of the "Hydrogen Economy" in Washington DC
9. GreenHouse Energy, Governor Schwarzenegger Join in Driving the Future of Fueling in California
10. POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009
11. Health Strategies Group Forecasts Emerging Trends in Future Sales Force Models at the SPBT 2009 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Brain Sentinel, ... begin marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting System. ... healthcare facilities during periods of rest. A lightweight, non-invasive monitor is placed on ...
(Date:2/23/2017)... INDIANAPOLIS, Ind. (PRWEB) , ... February 23, 2017 ... ... Commercialization Award during the 12th annual Inventors Recognition Reception at Purdue Research ... annually to a faculty member in recognition of outstanding contributions to, and success ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift ... new partnership with Compass Research . GGI's mission is to advance global health ... a child in need in honor of each clinical trial volunteer. The vision of ...
(Date:2/23/2017)... 2017 Aviva Systems Biology Corporation (ASB) ... of GenWay Biotech Incorporated, a protein solutions and ... offering for both the research and diagnostic markets. ... enhance capabilities for both entities. GenWay,s 18 years of ... nicely complement ASB,s objective to become a leading ...
Breaking Biology Technology:
(Date:1/23/2017)... DENVER , Jan. 23, 2017  The latest ... biometric smartphone prices have dropped dramatically. The quarterly average ... Q1 2013 to $276 in Q4 2016.  There are ... average price of $116, up from just 28 a ... According to Maxine Most , Acuity ...
(Date:1/19/2017)... PUNE, India , January 19, 2017 According ... Market, Opportunities and Forecast, 2014 - 2022," the global biometric sensor market ... 9.6% from 2016 to 2022. In 2015, Asia-Pacific dominated ... both public and private sectors. Continue Reading ... ...
(Date:1/18/2017)... 2017  In vitro diagnostic (IVD) companies were very ... (M&A), and Kalorama Information expects that trend to continue ... shifting. Generally, uncertainty in reimbursement and healthcare reform in ... changed the acquisitions landscape. Instead of looking to buy ... partners outside of their home country and also to ...
Breaking Biology News(10 mins):